ICPT Announces Positive Results from Phase 2 AESOP Trial Evaluating OCA for the Treatment of Patients with Primary Sclerosing Cholangitis https://globenewswire.com/news-release/2017/10/23/1151797/0/en/Intercept-Announces-Positive-Results-from-Phase-2-AESOP-Trial-Evaluating-OCA-for-the-Treatment-of-Patients-with-Primary-Sclerosing-Cholangitis-at-The-Liver-Meeting-2017.html - OCA met the primary endpoint of alkaline phosphatase (ALP) reduction at 24 weeks - Results presented in a late-breaking oral session